Citius Pharmaceuticals Income Statement (2010-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Shares Outstanding (Entity) (Quarter)	5.84M	4.34M	5.84M	5.85M	5.85M	5.85M	5.85M	5.85M	6.35M	6.35M	6.36M	6.36M	7.23M	7.25M	7.73M	8.76M	11.01M	11.07M	22.38M	22.38M
Revenue & cost
Revenue (Quarter)																			3.94M	1.67M
Gross Profit (Quarter)																			3.15M	1.34M
Operating items
Research & Development (Quarter)	2.20M	5.00M	5.46M	3.45M	4.89M	3.86M	3.45M	4.73M	3.76M	2.88M	2.62M	3.61M	2.76M	2.91M	2.13M	3.77M	1.62M	1.64M	1.60M	1.63M
Wages, Salaries and Other (Quarter)
Selling, General & Administrative (Quarter)	3.41M	2.45M	2.90M	3.12M	3.02M	2.72M	2.60M	4.79M	3.73M	4.17M	3.66M	4.29M	4.81M	5.49M	5.39M	4.79M	4.45M	3.91M	5.72M	26.39M
Other Operating Expenses (Quarter)	0.16M	0.24M	0.03M	0.03M	0.05M	0.13M	3.80M	0.30M	0.34M	3.08M	3.06M	3.08M	3.06M	2.64M	2.52M	2.70M	2.72M	2.89M	4.85M	5.51M
Operating Expenses (Quarter)	5.98M	5.20M	9.26M	7.59M	8.92M	7.55M	7.25M	10.69M	8.67M	10.12M	9.34M	10.97M	10.63M	11.05M	10.04M	11.26M	8.79M	8.44M	12.17M	33.53M
Operating Income (Quarter)	-5.98M	-5.20M	-9.26M	-7.59M	-8.92M	-7.55M	-7.25M	-10.69M	-8.67M	-10.12M	-9.34M	-10.97M	-10.63M	-11.05M	-10.04M	-11.26M	-8.79M	-8.44M	-9.02M	-32.19M
EBIT (Quarter)	-5.98M	-5.20M	-9.26M	-7.59M	-8.92M	-7.55M	-7.25M	-10.69M	-8.67M	-10.12M	-9.34M	-10.97M	-10.63M	-11.05M	-10.04M	-11.26M	-8.79M	-8.44M	-9.02M	-32.19M
Non-operating items
Interest & Investment Income (Quarter)	0.10M	0.08M	0.03M	0.03M	0.05M	0.13M	0.21M	0.30M	0.34M	0.32M	0.25M	0.18M	0.20M	0.12M	0.02M	0.01M	0.02M	0.05M	0.05M	0.05M
Other Non Operating Income (Quarter)	-1.45M						3.59M					2.39M
Non Operating Income (Quarter)	0.16M	0.24M					3.80M	0.30M	0.34M	0.32M	0.25M	2.57M	0.20M	0.12M	0.02M	0.01M	-0.15M	-0.04M	-0.11M	3.85M
Net income details
EBT (Quarter)	-15.01M	-5.13M	-9.23M	-7.56M	-8.86M	-7.41M	-3.45M	-10.38M	-8.34M	-9.80M	-9.09M	-8.40M	-10.43M	-10.93M	-10.02M	-11.25M	-8.94M	-8.48M	-9.13M	-28.34M
Tax Provisions (Quarter)							0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.14M	0.26M	0.26M	0.26M	0.26M	0.26M	-0.23M
Profit After Tax (Quarter)	-5.82M	-4.96M	-9.23M	-7.56M	-8.86M	-7.99M	-3.59M	-10.53M	-8.48M	-9.94M	-9.23M	-8.54M	-10.57M	-11.08M	-10.28M	-11.51M	-9.20M	-8.74M	-9.39M	-28.11M
Income from Non-Controlling Interests (Quarter)															-0.51M	-0.59M	-0.41M	-0.78M	-1.17M	-6.88M
Income from Continuing Operations (Quarter)	-15.01M	-5.13M	-9.23M	-7.56M	-8.86M	-7.41M	-3.59M	-10.53M	-8.48M	-9.94M	-9.23M	-8.54M	-10.57M	-11.08M	-10.28M	-11.51M	-9.20M	-8.74M	-9.39M	-28.11M
Consolidated Net Income (Quarter)	-15.01M	-5.13M	-9.23M	-7.56M	-8.86M	-7.41M	-3.59M	-10.53M	-8.48M	-9.94M	-9.23M	-8.54M	-10.57M	-11.08M	-10.28M	-11.51M	-9.20M	-8.74M	-9.39M	-28.11M
Income towards Parent Company (Quarter)	-15.01M	-5.13M	-9.23M	-7.56M	-8.86M	-7.41M	-3.59M	-10.53M	-8.48M	-9.94M	-9.23M	-8.54M	-10.57M	-11.08M	-10.28M	-11.51M	-9.20M	-8.74M	-9.39M	-28.11M
Preferred Dividend Payments (Quarter)	1.45M
Net Income towards Common Stockholders (Quarter)	-7.27M	-4.96M	-9.23M	-7.56M	-8.86M	-7.99M	-3.59M	-10.53M	-8.48M	-11.10M	-9.23M	-8.54M	-10.89M	-11.52M	-9.77M	-10.92M	-8.79M	-7.96M	-8.22M	-21.23M
Additional items
EPS (Basic) (Quarter)	-1.33	-1.14	-1.58	-1.29	-1.52	-1.37	-0.61	-1.80	-1.38	-1.83	-1.45	-1.34	-1.57	-1.71	-1.30	-1.27	-0.80	-0.72	-0.38	-0.95
EPS (Diluted) (Quarter)	-1.33	-1.14	-1.58	-1.29	-1.52	-1.37	-0.61	-1.80	-1.38	-1.83	-1.45	-1.34	-1.57	-1.71	-1.30	-1.27	-0.80	-0.72	-0.38	-0.95
Shares Outstanding (Quarter)	5.49M	4.34M	5.84M	5.84M	5.85M	5.84M	5.85M	5.85M	6.15M	6.05M	6.36M	6.36M	6.95M	6.73M	7.49M	8.58M	11.01M	11.07M	21.50M	22.38M
Shares Outstanding (Diluted) (Quarter)	5.49M	4.34M	5.84M	5.84M	5.85M	5.84M	5.85M	5.85M	6.15M	6.05M	6.36M	6.36M	6.95M	6.73M	7.49M	8.58M	11.01M	11.07M	21.50M	22.38M
EBITDA (Quarter)	-5.98M	-5.20M	-9.26M	-7.59M	-8.92M	-7.55M	-7.25M	-10.69M	-8.67M	-10.12M	-9.34M	-10.97M	-10.63M	-11.05M	-10.04M	-11.26M	-8.79M	-8.44M	-9.02M	-32.19M
Interest Expenses (Quarter)	9.13M	0.00M		2.75M	0.30M	0.87M	0.17M	0.75M	0.82M	0.06M	0.46M	1.07M	0.02M	5.39M	0.01M	0.18M	0.19M	0.10M	6.88M	6.88M
Tax Rate (Quarter)							-4.17	-1.39	-1.73	-1.47	-1.58	-1.71	-1.38	-1.32	-2.64	-2.35	-2.96	-3.12	-2.89	0.82

Research Tools

Datasets

Plans

Developers

Citius Pharmaceuticals CTXR Income Statement (2010-2026)

Research Tools

Datasets

Plans

Developers

Citius Pharmaceuticals CTXR Income Statement (2010-2026)

Create an account

Sign In

Reset Password